CNRC logo
CNRC Banner
Home Logo About Logo Research Logo Studies Logo News Logo
Home About Research Mind Matters News and Events
  Publications
     
 
Date Links
Books and Chapters 2004 2003 2002 2001 2000 1999 1995 1993
Publications 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
 
 

1.Sharma T & Harvey P (2000)

Cognition in Schizophrenia: Impairments, Importance and Treatment Strategies

   
 

2. Sharma T & Chitnis X (2001)

Brain Imaging in Schizophrenia: Insights and Applications Remedica Publishing Limited.

   
 

3. Sharma T & Harvey P (2002)

Understanding and Treating Cognition in Schizophrenia – A Clinician’s Handbook Martin Dunitz Publishing PAPERS

   
 


1. Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SCR, Sharma T (1999)

Differences in frontal cortical activation by a working memory task following substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proceedings of the National Academy of Sciences 96 (23): 13432-13437

 

2. Kumari V, Soni W, Sharma T (1999)

Normalization of information processing deficits in schizophrenia with clozapine. American Journal of Psychiatry 156:7, 1046-1051

 

3. Longworth C, Honey G and Sharma T (1999)

Functional magnetic resonance imaging in neuropsychiatry. British Medical Journal 319: Iss 7224 1551-1554

 

4. Frederiks, ME, Lu A, Aylward E, Barta P, Pulver A, Sharma T, Pearlson, G (2000)

Sex differences in inferior parietal lobule volume in schizophrenia. American Journal of Psychiatry 157 (3): 422-427

 

5. Honey GD, Bullmore ET, Sharma T (2000)

Prolonged reaction time to a verbal working memory task predicts increased power of posterior parietal cortical activation. Neuroimage 12: 495-503.

 

6. Fannon D, Tennakoon L, Sumich A, O’Ceallaigh S, Doku V, Chitnis X, Lowe J, Soni W, Sharma T (2000)

Third ventricle enlargement and developmental delay in first episode psychosis: preliminary findings. British Journal of Psychiatry 117: 354-359.

 

7. Tennakoon L, Fannon D, Dolu F, O'Ceallaigh S, Santamarie M, Kuipers E, and Sharma T (2000)

The experience of caregiving: relatives of people experincing of first episode psychosis. British Journal of Psychiatry 177: 529-533.

 

8. Russell TA, Rubia K, Bullmore ET, Soni W, Suckling J, Brammer MJ, Simmons A, Williams SCR, Sharma T (2000)

Exploring the social brain in schizophrenia: left prefrontal underactivation during mental state attribution. American Journal of Psychiatry 157 (12): 2040-2042.

 

9. Ettinger U, Chitnis XA, Kumari V, Fannon DG, Sumich AL, O'Ceallaigh S, Doku VC, Sharma T (2001)

Magnetic resonance imaging of the thalamus in first-episode psychosis. American Journal of Psychiatry 158: 116-118.

 

10. Fannon D, Chitnis X, Doku V, Tennakoon L, O'Ceallaigh S, Soni W, Sumich A, Lowe J, Santamarie M, Sharma T (2000)

Features of structural brain abnormality detected in early first episode psychosis. American Journal of Psychiatry 157(11): 1829-34

 

11. Rubia K, Overmeyer S, Russell T, Brammer MJ, Bullmore ET, Sharma T, Simmons A, Williams SCR, Andrew CM, Taylor E (2000)

Mapping motor inhibition: Generic brain activations across different versions of go-no-go and stop tasks. Neuroimage 13(2):250-61

 

12. Spence SA, Liddle PF, Stefan M, Sharma T, Hellewell JSE, Hirsch SR, Murray RM, Deakin JFW, Frith CD, Grasby PM (2000)

Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk: Focal dysfunction and distributed disconnectivity reappraised. British Journal of Psychiatry 176:52-60.

 

13. Kumari V, Zachariah E, Mehrotra R, Taylor D, Sharma T (2001)

Effects of procyclidine on prepulse inhibition of the acoustic startle response in healthy human volunteers. Psychopharmacology 154: 221-229.

 

14. Sharma T (2001)

Quetiapine – efficacy in different domains. European Journal of Neuropsychopharmacology, October 2001; Vol 11 (S4): S385-S390.

 

15. Kumari V, Sharma T (2002)

Effects of Typical and Atypical Antipsychotics on Prepulse Inhibition in Schizophrenia: A Critical Evaluation of Current Evidence and directions for future research. Psychopharmacology . June;162(2):97-101.

 

16. Ettinger U, Kumari V, Chitnis XA, Corr PJ, Sumich AL, Rabe-Hesketh S, Crawford TJ, Sharma T. (2002)


Relationship between brain structure and saccadic eye movements in healthy humans. Neuroscience Letters. Aug 16;328(3):225-8.

 

17. Kumari V, Soni W, Sharma T. (2002)

Prepulse Inhibition of the startle response in risperidone treated patients:
Comparison with typical antipsychotics. Schizophrenia Research 55 (1-2): 139-46.

 

18. Welchew DE, Honey GD, Sharma T, Robbins TW, Bullmore ET. (2002)

Multidimensional scaling of integrated
neurocognitive function and schizophrenia as a disconnexion disorder. Neuroimage. 17(3):1227-39.

 

19. Sharma T, Kumari V (in press)

Eleventh biennial winter workshop on schizophrenia: Journal of Schizophrenia and Brain Research

 


20. Hughes C, Kumari V, Soni W, Das M, Binneman B, Drozd S, O’Neil S, Mathew V, Sharma T (2003)

Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophrenia Research. Feb 1;59(2-3):137-46.

 

21. Ulrich Ettinger, Veena Kumari, Elizabeth Zachariah, Adrian Galea, Trevor J Crawford, Philip J Corr, David Tarylor, Mrigendra Das, Tonmoy Sharma.

Effects of Procyclidine on Eye Movements in Schizophrenia. Neuropsychopharmacology 2003. Published 26/11/03

 

22. Kumari V, Gray Jeffrey A, Ffytche Dominic, Mitterschiffthaler Martina T, Das Mrigen, Zachariah Elizabeth, Vythelingum Goparlen N, Williams Steven CR, Simmons Andrew, Sharma Tonmoy.

Cognitive Effects of Nicotine in Humans: An fMRI Study. Published NeuorImage February 2003.

 


23. Sharma T, Hughes C, Soni W, Kumari V (2002)

Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia. Psychopharmacology. Published 4th July 2003

 
Books and Chapters 2004, 2003, 2002, 2001, 2000, 1999, 1995, 1993,
 

Gurling HMD, Sharma T 1993

Genetic linkage analysis and clinical approaches to the resolution of heterogeneity in the schizophrenias

Gershon, E., Cloninger, C.R. (eds)

New Genetic Approaches to Mental Disorders.  American Psychiatric Press, Washington, USA

 

Sharma T  1995

Biological markers in schizophrenia (pp 210-225)

In: Khanna, S., Channabasavanna, S.M. & Keshavan, M.S. (eds) Biological Methods in Psychiatry.

Tata McGraw-Hill Publishing Company Ltd., London
 

Sharma, T  1999

Treatment of cognitive deficits in first-episode psychosis (pp 24-31)  In Keefe, R (ed) Improving Cognitive function in Schizophrenia
Science Press Ltd, London. 1999 – updated 2003.

 

Stuttaford, T, Sharma , T,1999

In your right mind.

Faber and Faber

 

Sharma T & Harvey P 2000

Cognition in Schizophrenia: Importance, Impairment and Treatment Strategies

 

Sharma T & Harvey PD. 2001

Cognitive enhancement as a treatment strategy in schizophrenia. In: Schizophrenia and Cognition
Sharma & Harvey (eds) Oxford University Press Oxford

 

Sharma T & Chitnis X 2001

Brain Imaging in Schizophrenia: Insights and Applications
Remedica Publishing Limited.

 

Sharma T & Harvey P 2002

Understanding and Treating Cognition in Schizophrenia – A   Clinician's Handbook
Martin Dunitz Publishing

 

Russell T and Sharma T 2003

Social cognition at the neural level: investigations in autism, psychopathy and schizophrenia. The Social Brain

John Wiley & Sons Ltd.  2003 Dec
 
 

Publications 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993

 
Publications 1993
 

Sharma T, Murray RM

 
Aetiological theories in schizophrenia
Current Opinion In Psychiatry.  1993 6:80-84
 
Publications 1994
 

Kalsi G, Mankoo BS, Brynjolfsson J, Curtis D, Read T, Murphy P, Sharma T, Petursson H, Gurling HM.

The Marfan syndrome gene locus as a favoured locus for susceptibility to schizophrenia.
Psychiatr Genet. 1994 Winter;4(4):219-27.

 

Carson J, Sharma T

 
In-Patient psychiatric care – what helps? Staff and patient perspectives.
Journal of Mental Health.  1994 3:99-104
 

Sharma T, Boast N, Katona C

 
Patients' perspectives of Final MBBS students.
Medical Teacher.  1994 16(1):61-69
 
Publications 1995
 

Arranz MJ, Dawson E, Shaikh S, Sham P, Sharma T, Aitchison K, Crocq MA, Gill M, Kerwin R, Collier DA.

Cytochrome P4502D6 genotype does not determine response to clozapine.
Br J Clin Pharmacol. 1995 Apr;39(4):417-20.

 

Kalsi G, Mankoo BS, Curtis D, Brynjolfsson J, Read T, Sharma T, Murphy P, Petursson H, Gurling HM.

Exclusion of linkage of schizophrenia to the gene for the dopamine D2 receptor (DRD2) and chromosome 11q translocation sites.
Psychol Med. 1995 May;25(3):531-7.

 

Bullmore E, Brammer M, Rouleau G, Everitt B, Simmons A, Sharma T, Frangou S, Murray R, Dunn G.

Computerized brain tissue classification of magnetic resonance images: a new approach to the problem of partial volume artifact.
Neuroimage. 1995 Jun;2(2):133-47

 

Kalsi G, Brynjolfsson J, Butler R, Sherrington R, Curtis D, Sigmundsson T, Read T, Murphy P, Sharma T, Petursson H, et al.

Linkage analysis of chromosome 22q12-13 in a United Kingdom/Icelandic sample of 23 multiplex schizophrenia families.
Am J Med Genet. 1995 Aug 14;60(4):298-301.

 

Kalsi G, Curtis D, Brynjolfsson J, Butler R, Sharma T, Murphy P, Read T, Petursson H, Gurling HM.

Investigation by linkage analysis of the XY pseudoautosomal region in the genetic susceptibility to schizophrenia.
Br J Psychiatry. 1995 Sep;167(3):390-3.

 

Arranz M, Sharma T, Sham P, Kerwin R, Nanko S, Owen M, Gill M, Collier D.

Schizophrenia and the androgen receptor gene: report of a sibship showing co-segregation with Reifenstein syndrome but no evidence for linkage in 23 multiply affected families.
Am J Med Genet. 1995 Oct 9;60(5):377-81.

 

Gurling H, Kalsi G, Chih-Hui Chen A, Green M, Butler R, Read T, Murphy P, Curtis D, Sharma T, et AL, et al.

Schizophrenia susceptibility and chromosome 6p24-22.
Nat Genet. 1995 Nov;11(3):234-5.

 

Shaikh S, Collier DA, Sham P, Pilowsky L, Sharma T, Lin LK, Crocq MA, Gill M, Kerwin R.

Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients.
Am J Med Genet. 1995 Dec 18;60(6):541-5.

 

Sharma T

Schizophrenia:  A problem of compliance

Geriatric Medicine.  1995 25(9)14
 
Publications 1996
 

Pilowsky LS, Busatto GF, Taylor M, Costa DC, Sharma T, Sigmundsson T, Ell PJ, Nohria V, Kerwin RW.

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.
Psychopharmacology (Berl). 1996 Mar;124(1-2):148-53.

 

Sharma T, Carson J.

The idea of partnership is fine, but what about perceptions?
J Psychiatr Ment Health Nurs. 1996 Apr;3(2):133-4.

 

Wright P, Sham PC, Gilvarry CM, Jones PB, Cannon M, Sharma T, Murray RM.

Autoimmune diseases in the pedigrees of schizophrenic and control subjects.
Schizophr Res. 1996 Jul 5;20(3):261-7.

 

Mockler D, Riordan J, Sharma T.

A comparison of the NART (restandardized) and the NART-R (revised).
Br J Clin Psychol. 1996 Nov;35 ( Pt 4):567-72.

 

Sharma T, Kerwin R.

Biological determinants of difficult to treat patients with schizophrenia.
Br J Psychiatry Suppl. 1996 Dec;(31):5-9.

 

Sharma T

Schizophrenia: recent advances in psychopharmacology.
Br J Hosp Med. 1996 Feb 21-Mar 5;55(4):194-8.

 
Publications 1997
 

Frangou S, Sharma T, Alarcon G, Sigmudsson T, Takei N, Binnie C, Murray RM.

The Maudsley Family Study, II: Endogenous event-related potentials in familial schizophrenia.
Schizophr Res. 1997 Jan 17;23(1):45-53.

 

Frangou S, Sharma T, Sigmudsson T, Barta P, Pearlson G, Murray RM.

The Maudsley Family Study. 4. Normal planum temporale asymmetry in familial schizophrenia. A volumetric MRI study.
Br J Psychiatry. 1997 Apr;170:328-33.

 

Mockler D, Riordan J, Sharma T

Memory and intellectual deficits do not decline with age in schizophrenia.
Schizophr Res. 1997 Jul 25;26(1):1-7.

 

Frangou S, Aylward E, Warren A, Sharma T, Barta P, Pearlson G.

Small planum temporale volume in Down's syndrome: a volumetric MRI study.
Am J Psychiatry. 1997 Oct;154(10):1424-9.

 

Sharma T, du Boulay G, Lewis S, Sigmundsson T, Gurling H, Murray R.

The Maudsley Family Study. I: Structural brain changes on magnetic resonance imaging in familial schizophrenia.
Prog Neuropsychopharmacol Biol Psychiatry. 1997 Nov;21(8):1297-315.

 

Keshaven MS, Sharma T

 
High risk research in schizophrenia: Current status and the future
Schizophrenia Monitor.  1997 7:3
 

Sharma T

 
Are the ‘atypical' drugs better?
Cost and Options in Schizophrenia.  1997 12:8-10
 
Publications 1998
 

Griffiths TD, Sigmundsson T, Takei N, Frangou S, Birkett PB, Sharma T, Reveley AM, Murray RM.

Minor physical anomalies in familial and sporadic schizophrenia: the Maudsley family study.
J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):56-60.

 

Sharma T, Mockler D.

The cognitive efficacy of atypical antipsychotics in schizophrenia.
J Clin Psychopharmacol. 1998 Apr;18(2 Suppl 1):12S-9S.

 

Sharma T, Lancaster E, Lee D, Lewis S, Sigmundsson T, Takei N, Gurling H, Barta P, Pearlson G, Murray R.

Brain changes in schizophrenia. Volumetric MRI study of families multiply affected with schizophrenia--the Maudsley Family Study 5.
Br J Psychiatry. 1998 Aug;173:132-8.

 

Crawford TJ, Sharma T, Puri BK, Murray RM, Berridge DM, Lewis SW.

Saccadic eye movements in families multiply affected with schizophrenia: the Maudsley Family Study.
Am J Psychiatry. 1998 Dec;155(12):1703-10.

 

Sharma T

 
Newer atypical antipsychotic agents in the treatment of schizophrenia.
Family Medicine.  1998 2(6):6-7
 

Spence SA, Liddle PF, Stefan M, Sharma T, Hellewell JSE, Hirsch SR, Murray RM, Deakin JFW, Frith CD, Grasby PM

 
A PET study of brain association and functional connectivity during verbal fluency in normal subjects at genetic risk of schizophrenia, affected schizophrenic patients and normal controls.
Br J Psychiatry.  1998 176:52-60
 
Publications 1999
 

Wright IC, Ellison ZR, Sharma T, Friston KJ, Murray RM, McGuire PK.

Mapping of grey matter changes in schizophrenia.
Schizophr Res. 1999 Jan 4;35(1):1-14.

 

Curtis VA, Bullmore ET, Morris RG, Brammer MJ, Williams SC, Simmons A, Sharma T, Murray RM, McGuire PK.

Attenuated frontal activation in schizophrenia may be task dependent.
Schizophr Res. 1999 May 4;37(1):35-44.

 

Wright IC, Sharma T, Ellison ZR, McGuire PK, Friston KJ, Brammer MJ, Murray RM, Bullmore ET.

Supra-regional brain systems and the neuropathology of schizophrenia.
Cereb Cortex. 1999 Jun;9(4):366-78.

 

Kumari V, Soni W, Sharma T.

Normalization of information processing deficits in schizophrenia with clozapine.
Am J Psychiatry. 1999 Jul;156(7):1046-51.

 

Curtis VA, Bullmore ET, Brammer MJ, Wright IC, Williams SC, Morris RG, Sharma TS, Murray RM, McGuire PK.

Attenuated frontal activation during a verbal fluency task in patients with schizophrenia.
Am J Psychiatry. 1998 Aug;155(8):1056-63.

 

Stefanis N, Frangou S, Yakeley J, Sharma T, O'Connell P, Morgan K, Sigmudsson T, Taylor M, Murray R.

Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications.
Biol Psychiatry. 1999 Sep 1;46(5):697-702.

 

Sheringham J, Sharma T

 
Magnetic Resonance Imaging in schizophrenia.
Hospital Doctor.  1999 Sep 64
 

Dye SM, Spence SA, Bench CJ, Hirsch SR, Stefan MD, Sharma T, Grasby PM.

No evidence for left superior temporal dysfunction in asymptomatic schizophrenia and bipolar disorder. PET study of verbal fluency.
Br J Psychiatry. 1999 Oct;175:367-74.

 

Sharma T, Lancaster E, Sigmundsson T, Lewis S, Takei N, Gurling H, Barta P, Pearlson G, Murray R.

Lack of normal pattern of cerebral asymmetry in familial schizophrenic patients and their relatives--The Maudsley Family Study.
Schizophr Res. 1999 Nov 30;40(2):111-20.

 

Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T.

Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13432-7

 

Longworth C, Honey G, Sharma T.

Science, medicine, and the future: functional magnetic resonance imaging in neuropsychiatry.
BMJ. 1999 Dec 11;319(7224):1551-4.

 

Bullmore E, Brammer M, Williams SC, Curtis V, McGuire P, Morris R, Murray R, Sharma T.

Functional MR imaging of confounded hypofrontality.
Hum Brain Mapp. 1999;8(2-3):86-91.

 

Bullmore ET, Brammer MJ, Rabe-Hesketh S, Curtis VA, Morris RG, Williams SC, Sharma T, McGuire PK.

Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI.
Hum Brain Mapp. 1999;7(1):38-48.

 

Sharma T.

Cognitive effects of conventional and atypical antipsychotics in schizophrenia.
Br J Psychiatry Suppl. 1999;(38):44-51

 
Honey GD, Sharma T
 

Functional Magnetic Resonance Imaging: A window on the brain and the future of schizophrenia research.

Journal of Advances in Schizophrenia and Brain Research.  1999 1(4):106-110
 

Sheringham J, Sharma T

 
Neuroimaging in early recognition and treatment of Alzheimer's disease.
Geriatric Medicine.  1999 29(10):12
 

Sharma T, Sheringham J

 
To boldly go
Mnetal Health Care.  1999 21(9):296-297
 

Sharma T, Soni W

 

Effective treatment of schizophrenia with Quetiapine in a thirty four year old caucasian man.

International Journal of Psychiatry in Clinical Practice.  1999 3:205-207
 
Publications 2000
 

Narr KL, Thompson PM, Sharma T, Moussai J, Cannestra AF, Toga AW.

Mapping morphology of the corpus callosum in schizophrenia.
Cereb Cortex. 2000 Jan;10(1):40-9.

 

Spence SA, Liddle PF, Stefan MD, Hellewell JS, Sharma T, Friston KJ, Hirsch SR, Frith CD, Murray RM, Deakin JF, Grasby PM.

Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk. Focal dysfunction and distributed disconnectivity reappraised.
Br J Psychiatry. 2000 Jan;176:52-60.

 

Chua SE, Sharma T, Takei N, Murray RM, Woodruff PW.

A magnetic resonance imaging study of corpus callosum size in familial schizophrenic subjects, their relatives, and normal controls.
Schizophr Res. 2000 Feb 14;41(3):397-403.

 

Frederikse M, Lu A, Aylward E, Barta P, Sharma T, Pearlson G.

Sex differences in inferior parietal lobule volume in schizophrenia.
Am J Psychiatry. 2000 Mar;157(3):422-7.

 

Bullmore E, Horwitz B, Honey G, Brammer M, Williams S, Sharma T.

How good is good enough in path analysis of fMRI data?
Neuroimage. 2000 Apr;11(4):289-301.

 

Riley EM, McGovern D, Mockler D, Doku VC, OCeallaigh S, Fannon DG, Tennakoon L, Santamaria M, Soni W, Morris RG, Sharma T.

Neuropsychological functioning in first-episode psychosis--evidence of specific deficits.
Schizophr Res. 2000 May 25;43(1):47-55.

 

Kumari V, Soni W, Mathew VM, Sharma T.

Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication.
Arch Gen Psychiatry. 2000 Jun;57(6):609-14.

 

Fannon D, Tennakoon L, Sumich A, O'Ceallaigh S, Doku V, Chitnis X, Lowe J, Soni W, Sharma T.

Third ventricle enlargement and developmental delay in first-episode psychosis: preliminary findings.
Br J Psychiatry. 2000 Oct;177:354-9.

 

Kumari V, Sharma T.

The 10th Biennial Winter Workshop on Schizophrenia. A report.
Schizophr Res. 2000 Nov 30;46(1):65-72.

 

Fannon D, Chitnis X, Doku V, Tennakoon L, O'Ceallaigh S, Soni W, Sumich A, Lowe J, Santamaria M, Sharma T.

Features of structural brain abnormality detected in first-episode psychosis.
Am J Psychiatry. 2000 Nov;157(11):1829-34

 

Tennakoon L, Fannon D, Doku V, O'Ceallaigh S, Soni W, Santamaria M, Kuipers E, Sharma T.

Experience of caregiving: relatives of people experiencing a first episode of psychosis.
Br J Psychiatry. 2000 Dec;177:529-33.

 

Russell TA, Rubia K, Bullmore ET, Soni W, Suckling J, Brammer MJ, Simmons A, Williams SC, Sharma T.

Exploring the social brain in schizophrenia: left prefrontal underactivation during mental state attribution.
Am J Psychiatry. 2000 Dec;157(12):2040-2.

 

Aitchison KJ, Jordan BD, Sharma T.

The relevance of ethnic influences on pharmacogenetics to the treatment of psychosis.
Drug Metabol Drug Interact. 2000;16(1):15-38.

 

Kumari V, Sharma T

Applications of startle response modulation to study information processing deficits and their normalisation by new drug treatments in schizophrenia.

Archives of Indian Psychiatry.  2000 6(2):64-68.
 

Barkataki I, Kumari V, Sharma T

 
Perspectives on psychopathy.
The Psychologist.  2000 13(9):140-41.
 

Sharma T

 

Cognitive effects of antipsychotics in schizophrenia and relationship to quality of life.

British Journal of Psychiatry. 2000 176:92-93
 
Publications 2001
 

Ettinger U, Chitnis XA, Kumari V, Fannon DG, Sumich AL, O'Ceallaigh S, Doku VC, Sharma T.

Magnetic resonance imaging of the thalamus in first-episode psychosis.
Am J Psychiatry. 2001 Jan;158(1):116-8.

 

Rubia K, Russell T, Overmeyer S, Brammer MJ, Bullmore ET, Sharma T, Simmons A, Williams SC, Giampietro V, Andrew CM, Taylor E.

Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks.
Neuroimage. 2001 Feb;13(2):250-61.

 

Narr K, Thompson P, Sharma T, Moussai J, Zoumalan C, Rayman J, Toga A.

Three-dimensional mapping of gyral shape and cortical surface asymmetries in schizophrenia: gender effects.
Am J Psychiatry. 2001 Feb;158(2):244-55.

 

Kumari V, Zachariah E, Galea A, Mehrotra R, Taylor D, Sharma T.

Effects of procyclidine on prepulse inhibition of the acoustic startle response in healthy human volunteers.
Psychopharmacology (Berl). 2001 Mar;154(3):221-9.

 

Kumari V, Soni W, Sharma T.

Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia.
Hum Psychopharmacol. 2001 Jun;16(4):321-326.

 

Narr KL, Thompson PM, Sharma T, Moussai J, Blanton R, Anvar B, Edris A, Krupp R, Rayman J, Khaledy M, Toga AW.

Three-dimensional mapping of temporo-limbic regions and the lateral ventricles in schizophrenia: gender effects.
Biol Psychiatry. 2001 Jul 15;50(2):84-97.

 

Postma P, Kumari V, Sharma T, Hines M, Gray JA.

Startle response during smoking and 24 h after withdrawal predicts successful smoking cessation.
Psychopharmacology (Berl). 2001 Jul;156(2-3):360-7.

 

Rubia K, Russell T, Bullmore ET, Soni W, Brammer MJ, Simmons A, Taylor E, Andrew C, Giampietro V, Sharma T.

An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function.
Schizophr Res. 2001 Oct 1;52(1-2):47-55.

 

Sharma T.

Quetiapine--efficacy in different domains.
Eur Neuropsychopharmacol. 2001 Oct;11 Suppl 4:S385-90. Review.

 

Curtis VA, Dixon TA, Morris RG, Bullmore ET, Brammer MJ, Williams SC, Sharma T, Murray RM, McGuire PK.

Differential frontal activation in schizophrenia and bipolar illness during verbal fluency.
J Affect Disord. 2001 Oct;66(2-3):111-21.

 

Steel C, Haworth EJ, Peters E, Hemsley DR, Sharma T, Gray JA, Pickering A, Gregory L, Simmons A, Bullmore ET, Williams SC.

Neuroimaging correlates of negative priming.
Neuroreport. 2001 Nov 16;12(16):3619-24.

 

Sharma T, Sheringham J

 
Drug research in schizophrenia: Visualising the future?
Progress in Neurology and Psychiatry.  2001 4(6):18-21
 

Sharma T, Sheringham J

 
fMRI in schizophrenia: past, present and future.
Update. 2001 63(7):484-486
 
Publications 2002
 

Honey GD, Bullmore ET, Sharma T.

De-coupling of cognitive performance and cerebral functional response during working memory in schizophrenia.
Schizophr Res. 2002 Jan 1;53(1-2):45-56.

 

Zachariah E, Kumari V, Galea A, Das M, Mehrotra R, Taylor D, Ruprah M, Sharma T.

Effects of oral procyclidine administration on cognitive functions in healthy subjects: implications for schizophrenia.
J Clin Psychopharmacol. 2002 Apr;22(2):224-6.

 

Schulze K, McDonald C, Frangou S, Sham P, Grech A, Toulopoulou T, Walshe M, Sharma T, Sigmundsson T, Taylor M, Murray RM.

Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives.
Biol Psychiatry. 2003 Apr 1;53(7):562-70.

 

Kumari V, Soni W, Sharma T.

Prepulse inhibition of the startle response in risperidone-treated patients: comparison with typical antipsychotics.
Schizophr Res. 2002 May 1;55(1-2):139-46.

 

Sharma T, Galea A, Zachariah E, Das M, Taylor D, Ruprah M, Kumari V.

Effects of 10 mg and 15 mg oral procyclidine on critical flicker fusion threshold and cardiac functioning in healthy human subjects.
J Psychopharmacol. 2002 Jun;16(2):183-7.

 

Kumari V, Mitterschiffthaler MT, Sharma T.

Neuroimaging to predict preclinical Alzheimer's disease.
Hosp Med. 2002 Jun;63(6):341-5.

 

Mitterschiffthaler MT, Kumari V, Sharma T.

Brain imaging: a key to understanding depression.
Hosp Med. 2002 Jun;63(6):332-6.

 

Sheringham J, Kumari V, Sumich A, Sharma T.

Neuroimaging in schizophrenia: from theory to practice.
Hosp Med. 2002 Jun;63(6):328-31.

 

Sharma T.

Atypical antipsychotics and cognition in schizophrenia.
Arch Gen Psychiatry. 2002 Jun;59(6):571-2; author reply 573-5.

 

Sumich A, Chitnis XA, Fannon DG, O'Ceallaigh S, Doku VC, Falrowicz A, Marshall N, Matthew VM, Potter M, Sharma T.

Temporal lobe abnormalities in first-episode psychosis.
Am J Psychiatry. 2002 Jul;159(7):1232-5.

 

Kumari V, Sharma T.

Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research.
Psychopharmacology (Berl). 2002 Jul;162(2):97-101.

 

Ettinger U, Kumari V, Chitnis XA, Corr PJ, Sumich AL, Rabe-Hesketh S, Crawford TJ, Sharma T.

Relationship between brain structure and saccadic eye movements in healthy humans.
Neurosci Lett. 2002 Aug 16;328(3):225-8.

 

Kumari V, Gray JA, Honey GD, Soni W, Bullmore ET, Williams SC, Ng VW, Vythelingum GN, Simmons A, Suckling J, Corr PJ, Sharma T.

Procedural learning in schizophrenia: a functional magnetic resonance imaging investigation.
Schizophr Res. 2002 Sep 1;57(1):97-107.

 

Das M, Barkataki I, Kumari V, Sharma T.

Neuroimaging violence in the mentally ill: what can it tell us?
Hosp Med. 2002 Oct;63(10):604-9.

 

Welchew DE, Honey GD, Sharma T, Robbins TW, Bullmore ET.

Multidimensional scaling of integrated neurocognitive function and schizophrenia as a disconnexion disorder.
Neuroimage. 2002 Nov;17(3):1227-39.

 

Buckley PF, Strakowskis S, Sharma T, Murphy K, O'Callaghan E, Mahadik S, Tune L, Green A, Emsley R, Wirshing D, Lauriello J, Joubert A, Thompson K

 
Schizophrenia: Contemporary clinical perspectives
Psychiatric Clinics of N.America. 2002 Nov
 

Sharma T.

Impact on cognition of the use of antipsychotics.
Curr Med Res Opin. 2002;18 Suppl 3:s13-7.

 

Sharma T

 

The importance of recognising cognitive impairment in schizophrenia: Effect of long term outcome.

Featured article in www.psychiatry24x7.com  2002
 
Keshavan M, Sharma T
 
Assessing premorbid risk in schizophrenia: An update
Journal of Schizophrenia and Brain Research. 2002.
 
Hughes C, Kumari V, Sharma T
 
Cognitive Enhancement Strategies in schizophrenia
Journal of Advances in Schizophrenia and Brain Research.Vol 4 (4):123-128
 
Publications 2003
 

Sumich AL, Kumari V, Sharma T.

Neuroimaging of sexual arousal: research and clinical utility.
Hosp Med. 2003 Jan;64(1):28-33.

 

Sharma T

Characterisation of cognitive impairment in schizophrenia.
Lancet Neurol. 2003 Jan;2(1):10.

 

Hughes C, Kumari V, Soni W, Das M, Binneman B, Drozd S, O'Neil S, Mathew V, Sharma T.

Longitudinal study of symptoms and cognitive function in chronic schizophrenia.
Schizophr Res. 2003 Feb 1;59(2-3):137-46.

 

Mitterschiffthaler MT, Kumari V, Malhi GS, Brown RG, Giampietro VP, Brammer MJ, Suckling J, Poon L, Simmons A, Andrew C, Sharma T.

Neural response to pleasant stimuli in anhedonia: an fMRI study.
Neuroreport. 2003 Feb 10;14(2):177-82.

 

Kumari V, Gray JA, Geyer MA, ffytche D, Soni W, Mitterschiffthaler MT, Vythelingum GN, Simmons A, Williams SC, Sharma T.

Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects.
Psychiatry Res. 2003 Feb 15;122(2):99-113.

 

Kumari V, Zachariah E, Galea A, Jones HC, Das M, Mehrotra R, Taylor D, Sharma T.

Effects of acute procyclidine administration on prepulse inhibition of the startle response in schizophrenia: a double-blind, placebo-controlled study.
J Psychopharmacol. 2003 Mar;17(1):89-95.

 

Sharma T, Antonova L.

Cognitive Function in Schizophrenia. Deficits, Functional Consequences, and Future Treatment.
Psychiatr Clin North Am. 2003 Mar;26(1):25-40.

 

Schulze K, McDonald C, Frangou S, Sham P, Grech A, Toulopoulou T, Walshe M, Sharma T, Sigmundsson T, Taylor M, Murray RM.

Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives.
Biol Psychiatry. 2003 Apr 1;53(7):562-70.

 

Kumari V, Gray J, Gupta P, Luscher S, Sharma T

Sex differences in prepulse inhibition: Conceptual and methodological issues.

Personality and Individual Differences.  2003 May
 

Sharma T.

Insights and treatment options for psychiatric disorders guided by functional MRI.
J Clin Invest. 2003 Jul;112(1):10-8.

 

Ettinger U, Kumari V, Crawford TJ, Davis RE, Sharma T, Corr PJ.

Reliability of smooth pursuit, fixation, and saccadic eye movements.
Psychophysiology. 2003 Jul;40(4):620-8.

 

Kumari V, Gray JA, ffytche DH, Mitterschiffthaler MT, Das M, Zachariah E, Vythelingum GN, Williams SC, Simmons A, Sharma T.

Cognitive effects of nicotine in humans: an fMRI study.
Neuroimage. 2003 Jul;19(3):1002-13.

 

Sharma T.

Insights and treatment options for psychiatric disorders guided by functional MRI.
J Clin Invest. 2003 Jul;112(1):10-8.

 

Honey GD, Sharma T, Suckling J, Giampietro V, Soni W, Williams SC, Bullmore ET.

The functional neuroanatomy of schizophrenic subsyndromes.
Psychol Med. 2003 Aug;33(6):1007-18.

 

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
Am J Psychiatry. 2003 Aug;160(8):1396-404.

 

Sharma T, Hughes C, Soni W, Kumari V.

Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia.
Psychopharmacology (Berl). 2003 Sep;169(3-4):398-403.

 

Fannon D, Simmons A, Tennakoon L, O'Ceallaigh S, Sumich A, Doku V, Shew C, Sharma T.

Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia.
Biol Psychiatry. 2003 Sep 15;54(6):587-98.

 

Kumari V, Mitterschiffthaler MT, Teasdale JD, Malhi GS, Brown RG, Giampietro V, Brammer MJ, Poon L, Simmons A, Williams SC, Checkley SA, Sharma T.

Neural abnormalities during cognitive generation of affect in treatment-resistant depression.
Biol Psychiatry. 2003 Oct 15;54(8):777-91.

 

Ettinger U, Kumari V, Zachariah E, Galea A, Crawford TJ, Corr PJ, Taylor D, Das M, Sharma T.

Effects of procyclidine on eye movements in schizophrenia.
Neuropsychopharmacology. 2003 Dec;28(12):2199-208.

 

Narr KL, Sharma T, Woods RP, Thompson PM, Sowell ER, Rex D, Kim S, Asuncion D, Jang S, Mazziotta J, Toga AW.

Increases in regional subarachnoid CSF without apparent cortical gray matter deficits in schizophrenia: modulating effects of sex and age.
Am J Psychiatry. 2003 Dec;160(12):2169-80.

 
 
Publications 2004
 

Keefe R, Seidman L, Christenson B, Hamer R, Sharma T, Sitskoorn M, Lewine R, Yurgelin-Todd D, Gur R, Tohen M, Tollefson G, Sanger T, Lieberman J, HGDH Study Group (2004)

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
Am J Psychiatry. 2004 Jun;161(6):985-95.

 

Antonova E, Sharma T, Morris R, Kumari V (2004)

The relationship between brain structure and neurocognition in schizophrenia : A selective review.
Schizophr Res. 2004 Oct 1;70(2-3):117-45.

 

Ettinger U, Kumari V, Crawford TJ, Corr PJ, Das M, Zachariah E, Hughes C, Sumich AL, Rabe-Hesketh S, Sharma T.

Smooth pursuit and antisaccade eye movements in siblings discordant for schizophrenia.
J Psychiatr Res. 2004 Mar-Apr;38(2):177-84.

 
Knowles L, Sharma T.
Identifying vulnerability markers in prodromal patients – A step in the right direction for schizophrenia prevention.
CNS Spectr. 2004 Aug;9(8):595-602.
 
Abdi Z, Sharma T
Social Cognition and Its Neural
Correlates in Schizophrenia and Autism
CNS Spectr. 2004 May;9(5):335-43

 

 

 

Kumari V, Aasen I, Sharma T
Sex differences in prepulse inhibition deficits in chronic schizophrenia
Schizophr Res. 2004; 69(2-3):219-35

 

 
Bajaj P, Sharma
Neurodevelopment and neurodegeneration in schizophrenia.
In: Malcolm Lader (ed.) Fast Facts: Psychiatry Highlights 2003-04. Health Press, Oxford.

 

 


 
Publications 2005
 
Ettinger U, Kumari V, Crawford T, Flak V, Sharma T, Davis R, Corr P
Saccadic eye movements, schizotypy, and the role of neuroticism

Biol Psychol. 2005 Jan;68(1):61-78.

 
Veena Kumari, T Elena Antonova, Elizabeth Zachariah, Adrian Galea, Ingrid Aasen, Ulrich Ettinger, Martina T. Mitterschiffthaler, and Tonmoy Sharma
 
Structural brain correlates of prepulse inhibition of the acoustic
startle response in healthy humans
NeuroImage 26 (2005) 1052– 1058
 
J. Harrison, D. Wilkinson, R. Jones,Bill Mann, Sangeeta Goswami,T. Sharma
Sensitivity of the Cogtest system to scopolamine challange: Relevance to studies of cognitive enhancement in schizophrenia
Clinical Neuropsychiatry (2005) , 2 , 2
 
Kumari V, Sharma T
Does Cholinergic facilitation enhance cognitive function in schizophrenia?
Clinical Neuropsychiatry (2005) , 2 , 2, 116-122
 
Veena Kumari, Mrigen Das, Elizabeth Zachariah, Ulrich Ettinger, Tonmoy Sharma
Reduced prepulse inhibition in unaffected siblings of
schizophrenia patients
 
Ingrid Aasen, Veena Kumari, and Tonmoy Sharma
Effects of Rivastigmine on Sustained Attention in Schizophrenia An fMRI Study
 
Elena Antonova, Veena Kumari, Robin Morris, Rozmin Halari, A Anilkumar, Ravi Mehrotra, and Tonmoy Sharma
The Relationship of Structural Alterations to Cognitive Deficits in Schizophrenia: A Voxel-Based Morphometry Study